Pomalidomide in patients with interstitial lung disease due to systemic sclerosis: a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group …
…, JHW Distler, S Korish, A Cooper, S Choi… - The Journal of …, 2018 - jrheum.org
Objective. To evaluate the safety and efficacy of pomalidomide (POM) on forced vital capacity
(FVC), modified Rodnan skin score (mRSS), and gastrointestinal (GI) symptomatology over …
(FVC), modified Rodnan skin score (mRSS), and gastrointestinal (GI) symptomatology over …
Goodness-of-fit tests for semiparametric models with multiple event-time data
A counting process approach to multiple event times modeled by an Andersen-Gill-type
extension of the Cox proportional hazards regression model is considered. Tests for checking …
extension of the Cox proportional hazards regression model is considered. Tests for checking …
[PDF][PDF] Safety and hemoglobin effect of the first 28-day dose cycle of sotatercept 0.7 mg/kg compared with lower doses and placebo for correction of anemia in …
…, J Kaupke, N Kopyt, S Choi… - The American …, 2014 - acceleron.comocreative.com
Mohamed El-Shahawy1; James Cotton2; Jeffrey Kaupke3; Nelson Kopyt4; Suktae Choi5;
William T. Smith5 … Mohamed El-Shahawy1; James Cotton2; Jeffrey Kaupke3; Nelson …
William T. Smith5 … Mohamed El-Shahawy1; James Cotton2; Jeffrey Kaupke3; Nelson …
Conditional exact tests for dichotomous data in the comparison of two treatments with one control group
SH Kang, S Choi - Drug Information Journal, 2008 - journals.sagepub.com
When we compare two treatments with one control group for dichotomous data whose
response rates are expected to be small, Dunnett's test based on the large sample theory is …
response rates are expected to be small, Dunnett's test based on the large sample theory is …
[BOOK][B] A nonparametric empirical Bayes approach to checking frailty models with recurrent event-time data
S Choi - 1998 - search.proquest.com
Recurrent event time data occur frequently in biomedical studies. For such data, Oakes (1992)
proposed a frailty model, extending the popular Andersen and Gill (1982) model. To …
proposed a frailty model, extending the popular Andersen and Gill (1982) model. To …
[CITATION][C] A randomized, placebo-controlled, double-blind, ascending-dose, safety, and pharmacokinetics study of CC-220 in subjects with systemic lupus …
…, M Weiswasser, S Choi… - ARTHRITIS & …, 2017 - … ST, HOBOKEN 07030-5774, NJ USA
[CITATION][C] CC-220 decreases B-cell subsets and plasmacytoid dendritic cells in systemic lupus erythematosus (SLE) patients and is associated with skin …
…, M Weiswasser, S Choi… - ARTHRITIS & …, 2017 - … ST, HOBOKEN 07030-5774, NJ USA
[CITATION][C] A phase 2 study of pomalidomide (CC-4047) to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics and effectiveness in subjects with …
…, A Cooper, PH Schafer, S Choi - ARTHRITIS & …, 2016 - … ST, HOBOKEN 07030-5774, NJ USA
[CITATION][C] Safety of exenatide once weekly in patients with type 2 diabetes treated with a thiazolidinedione
…, E Pintilei, L Pop, J Liutkus, S Choi… - …, 2010 - AMER DIABETES ASSOC 1701 N …
[CITATION][C] Congruence (and incongruence) between reaching A1C and plasma glucose (PG) goals in patients (Pts) with type 2 diabetes (T2D) and A1C< 7
S Choi, D Shrom, L Ilag - DIABETES, 2008 - AMER DIABETES ASSOC 1701 N …